IQVIA HOLDINGS INC. Cash and Cash Equivalents, Period Increase (Decrease)
IQVIA HOLDINGS INC. (IQV) reported Cash and Cash Equivalents, Period Increase (Decrease) of $47.00 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-07-24.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-07-24
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $2.00M.
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $45.00M, a 4400.00% increase year-over-year.
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $64.00M.
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$52.00M, a 125.87% decline year-over-year.
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$68.00M.
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$239.00M, a 208.14% decline from fiscal 2016.
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $221.00M, a 100.91% increase from fiscal 2015.
- IQVIA HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $110.00M, a 22.22% increase from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $47.00M 10-Q · filed 2019-07-24 | $111.00M derived: sum of 3 quarters · filed 2019-07-24 | $59.00M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2019-03-31 | $45.00M 10-Q · filed 2019-05-02 | $109.00M derived: sum of 2 quarters · filed 2019-05-02 | $57.00M derived: sum of 3 quarters · filed 2019-05-02 | -$24.00M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-12-31 | $64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $12.00M derived: sum of 2 quarters · filed 2019-02-19 | -$69.00M derived: sum of 3 quarters · filed 2019-07-24 | -$68.00M 10-K · filed 2019-02-19 | ||||
| 2018-09-30 | -$52.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$133.00M derived: sum of 2 quarters · filed 2019-07-24 | -$132.00M 10-Q · filed 2018-10-25 | -$276.00M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-06-30 | -$81.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$80.00M 10-Q · filed 2019-07-24 | -$224.00M derived: sum of 3 quarters · filed 2019-07-24 | -$23.00M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-02 | -$143.00M derived: sum of 2 quarters · filed 2019-05-02 | $58.00M derived: sum of 3 quarters · filed 2019-05-02 | $98.00M derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | -$144.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $57.00M derived: sum of 2 quarters · filed 2019-02-19 | $97.00M derived: sum of 3 quarters · filed 2019-02-19 | -$239.00M 10-K · filed 2019-02-19 | ||||
| 2017-09-30 | $201.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $241.00M derived: sum of 2 quarters · filed 2018-10-25 | -$95.00M 10-Q · filed 2018-10-25 | -$107.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-06-30 | $40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$296.00M 10-Q · filed 2018-07-27 | -$308.00M derived: sum of 3 quarters · filed 2019-02-19 | -$53.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-03-31 | -$336.00M 10-Q · filed 2018-05-04 | -$348.00M derived: sum of 2 quarters · filed 2019-02-19 | -$93.00M derived: sum of 3 quarters · filed 2019-02-19 | -$191.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2016-12-31 | -$12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $243.00M derived: sum of 2 quarters · filed 2019-02-19 | $145.00M derived: sum of 3 quarters · filed 2019-02-19 | $221.00M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | $255.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $157.00M derived: sum of 2 quarters · filed 2017-10-27 | $233.00M 10-Q · filed 2017-10-27 | $232.53M 10-Q · filed 2016-11-03 | $128.55M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-06-30 | -$98.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$22.00M 10-Q · filed 2017-08-04 | -$21.47M 10-Q · filed 2016-07-27 | -$126.45M derived: sum of 3 quarters · filed 2018-02-16 | $151.74M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-03-31 | $76.00M 10-Q · filed 2017-05-08 | $76.06M 10-Q · filed 2016-05-03 | -$28.45M derived: sum of 2 quarters · filed 2018-02-16 | $249.74M derived: sum of 3 quarters · filed 2018-02-16 | $274.29M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | -$104.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $173.74M derived: sum of 2 quarters · filed 2018-02-16 | $198.29M derived: sum of 3 quarters · filed 2018-02-16 | $110.00M 10-K · filed 2018-02-16 | $109.79M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $278.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $302.74M derived: sum of 2 quarters · filed 2016-11-03 | $214.45M 10-Q · filed 2016-11-03 | $437.56M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $24.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | -$63.74M 10-Q · filed 2016-07-27 | $159.37M derived: sum of 3 quarters · filed 2017-02-16 | $167.93M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | -$88.29M 10-Q · filed 2016-05-03 | $134.82M derived: sum of 2 quarters · filed 2017-02-16 | $143.38M derived: sum of 3 quarters · filed 2017-02-16 | $38.47M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $223.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $231.68M derived: sum of 2 quarters · filed 2017-02-16 | $126.76M derived: sum of 3 quarters · filed 2017-02-16 | $90.00M 10-K · filed 2017-02-16 | $89.22M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $8.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | -$96.35M derived: sum of 2 quarters · filed 2015-10-28 | -$133.11M 10-Q · filed 2015-10-28 | $35.32M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | -$104.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | -$141.68M 10-Q · filed 2015-07-29 | $26.76M derived: sum of 3 quarters · filed 2016-02-11 | $50.75M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | -$36.76M 10-Q · filed 2015-04-29 | $131.67M derived: sum of 2 quarters · filed 2016-02-11 | $155.66M derived: sum of 3 quarters · filed 2016-02-11 | $287.09M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $168.43M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $192.42M derived: sum of 2 quarters · filed 2016-02-11 | $323.85M derived: sum of 3 quarters · filed 2016-02-11 | $210.41M 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $23.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $155.42M derived: sum of 2 quarters · filed 2014-10-30 | $41.98M 10-Q · filed 2014-10-30 | $103.40M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $131.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $17.99M 10-Q · filed 2014-07-31 | $79.41M derived: sum of 3 quarters · filed 2015-02-12 | $109.48M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | -$113.44M 10-Q · filed 2014-05-01 | -$52.02M derived: sum of 2 quarters · filed 2015-02-12 | -$21.95M derived: sum of 3 quarters · filed 2015-02-12 | $8.02M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $61.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $91.49M derived: sum of 2 quarters · filed 2015-02-12 | $121.45M derived: sum of 3 quarters · filed 2015-02-12 | $51.43M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $30.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $60.04M derived: sum of 2 quarters · filed 2013-10-31 | -$9.99M 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $29.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$40.06M 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | -$70.03M 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | -$130.32M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |